SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017199
Filing Date
2019-05-08
Accepted
2019-05-08 16:12:26
Documents
60
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arwr-10q_20190331.htm 10-Q 1879343
2 EX-31.1 arwr-ex311_10.htm EX-31.1 10487
3 EX-31.2 arwr-ex312_9.htm EX-31.2 10930
4 EX-32.1 arwr-ex321_6.htm EX-32.1 6313
5 EX-32.2 arwr-ex322_8.htm EX-32.2 6560
  Complete submission text file 0001564590-19-017199.txt   5667153

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arwr-20190331.xml EX-101.INS 909452
7 XBRL TAXONOMY EXTENSION SCHEMA arwr-20190331.xsd EX-101.SCH 42624
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arwr-20190331_cal.xml EX-101.CAL 43816
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arwr-20190331_def.xml EX-101.DEF 162363
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arwr-20190331_lab.xml EX-101.LAB 373094
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arwr-20190331_pre.xml EX-101.PRE 304108
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38042 | Film No.: 19806732
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1